Stock Research: Apyx Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Apyx Medical

NasdaqGS:APYX US03837C1062
22
  • Value
    34
  • Growth
    72
  • Safety
    Safety
    24
  • Combined
    18
  • Sentiment
    35
  • 360° View
    360° View
    22
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Apyx Medical Corporation is an advanced energy technology company. It operates in the advanced energy and OEM industries, with its product Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market. In the last fiscal year, the company had a market cap of $77 million, profits of $29 million, revenue of $48 million, and 220 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 22 (better than 22% compared with alternatives), overall professional sentiment and financial characteristics for the stock Apyx Medical are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Apyx Medical. The consolidated Growth Rank has a good rank of 72, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 72% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 24 means that the share price of Apyx Medical is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 76% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 34, which means that the company has a riskier financing structure than 66% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 35, indicating professional investors are more pessimistic about the stock than for 65% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
24 51 45 21
Growth
72 5 97 49
Safety
Safety
34 46 63 48
Sentiment
35 12 17 60
360° View
360° View
22 1 77 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
10 13 47 72
Opinions Change
73 72 21 50
Pro Holdings
n/a 18 43 60
Market Pulse
26 9 5 27
Sentiment
35 12 17 60
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
24 51 45 21
Growth
72 5 97 49
Safety Safety
34 46 63 48
Combined
18 9 93 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
61 61 61 46
Price vs. Earnings (P/E)
64 74 77 37
Price vs. Book (P/B)
13 47 54 24
Dividend Yield
1 1 1 1
Value
24 51 45 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
21 10 75 73
Profit Growth
87 6 94 20
Capital Growth
46 34 61 35
Stock Returns
92 35 81 81
Growth
72 5 97 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
11 22 78 89
Refinancing
78 78 71 39
Liquidity
38 40 4 6
Safety Safety
34 46 63 48

Similar Stocks

Discover high‑ranked alternatives to Apyx Medical and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.